Keywords: evotec, sees, growth, revenues, first, nine, months

Evotec sees 26.8% growth in revenues

Article | 10 December 1999

For the first nine months of 1999, German drug discovery technologygroup Evotec Biosystems saw revenues rise 26.8% to 9.3 million Deutschemarks ($4.9 million). In ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in